Chugai pharmaceutical's sales share 2022, by disease area

Published by
Catharina Klein,
Jun 6, 2024
In the fiscal year 2022, the Japanese company Chugai Pharmaceutical Co., Ltd stated that approximately 37 percent of their total sales derived from products made for overseas markets. Due to the EU's approval of "Actemra" as a COVID-19 treatment, this segment has outperformed Chugai's domestic oncological product range.

Sales distribution of Chugai Pharmaceutical Co., Ltd. in 2022, by disease area

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

May 2023

Region

Japan

Survey time period

2022

Supplementary notes

**The overseas share includes products against Hemophilia A and Actemra which was approved as a COVID-19 medication in the EU.
**The primary share includes medication against Hemophilia A and neurological pathologies.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical market in Thailand "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical market in Thailand

Overview

6

Sales and production

5

Industry performance

5

Pharmaceutical licenses

5

International trade

7

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in Denmark Global pharmaceutical industryPharmaceutical industry in the U.S.Novo NordiskPharmaceutical industry in the UK
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.